Domain: Diagnosis/Neurogenetics
Treatment of ataxia – genetics based
Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025
Speaker: Ronald Buijsen
Leiden University, The Netherlands
Treatment of spasticity in children with rare neurological disorders – who, why, when and what?
Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025
Speaker: Annemieke Buizer
Amsterdam UMC, The Netherlands
Treatment of nano-rare neurological diseases
Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025
Speaker: Marlen Lauffer
Leiden University Medical Center, The Netherlands
Autonomic dysfunction in movement disorders
19 Nov. 2024
Speaker: Pietro Guaraldi
Azienda USL di Bologna, IRCCS Institute of Neurological Sciences, Bologna, Italy
Diagnostic approach to childhood-onset chorea
5 Nov. 2024
Speaker: Juan Darío Ortigoza-Escobar
Hospital Sant Joan de Déu, Barcelona, Spain
Clinical neurophysiology in dystonia
Autoimmune parkinsonism
Neuroimaging for Implantation and Programming in Dystonia Patients
The spectrum of genetic synucleinopathies
12 Mar. 2024
Speaker: Leonidas Stefanis
University of Athens Medical School, Athens, Greece
Neuropsychological assessment in primary progressive aphasia – recommendations and pitfalls in clinical practice
Newborn screening in leukodystrophies
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Autoimmune Chorea
Friedreich Ataxia
Dissecting Fahr’s disease
Frontotemporal dementia vs. primary psychiatric disorders
Non-pharmacological approaches to treatment in svPPA
FTD- in whom, when and how genetic testing should be applied
Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness
22 Nov. 2022
Speaker: Harro Seelaar & Dario Saracino
Erasmus University Medical Center, Rotterdam, Netherlands;
APHP – Pitié-Salpêtrière Hospital, Paris, France
VPS13A and XK bulk lipid transfer diseases (formerly the now obsolete Levine-Critchley syndrome)
DBS in Dystonia – Targets, programming and therapeutic challenges
Krabbe disease – natural history and treatment options
CACNA1A-related disorders: clinical presentation and therapeutic options
Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
27 Sep. 2022
Speaker: Daniel Weiß
Hertie Institute for Clinical Brain Research, University of Tübingen, Germany
Tau-targeting Therapies: Where are we heading to?
Vanishing white matter
13 Sep. 2022
Speaker: Marjo van der Knaap
VU University Medical Center Amsterdam, Netherlands
Young onset Parkinson’s disease – What is the difference?
Magnetic resonance imaging in the diagnostic assessment of cerebellar ataxias
28 Jun. 2022
Speaker: Jennifer Faber
German center for neurodegenerative disorders (DZNE), Bonn, Germany
